Professional Documents
Culture Documents
Safrany L, Lancet, Nov 1978: ES is increasingly replacing surgery in the treatment of choledocholithiasis Manegold BC, Langenbecks Arch Chir, Nov 1978: Late complications after EST are unknown and not to be expected
Early Complications of ES
Sedation Basket impaction Pancreatitis Bleeding Cholangitis Perforation Failure Early papillary stenosis
Late Complications of ES
Recurrent stones Acute cholecystitis Recurrent pancreatitis Re-stenosis of papilla Cholangiocarcinoma Rare complications: new GB stones, gallstone ileus, Ascaris in CBD
Study Seifert 1982 Escourou 1984 Liquory 1985 Leese 1985 Dresemann 1988 Kullman 1989
443 7% 43% 409 13% 57% 394 10.4% 3.3% Surgery 3.8% 185 3.8% 16.9% 2.8% Surgery 0.5% Surgery 5.6% 128 164 ES 16.5% 3.1% ALL Surgery 3.1%
Late Comp. Mortality 5.7% recurr 1.12% 3.1 restenosis 12% chole 1.5% 6% rec Pancr 4%
Pre-Laparoscopic Era
Great majority cholecystectomised Almost all those with GB in situ unfit for surgery Few specialised, skilled, high-volume centres Morbidity and mortality go with the pathology
Risk Factors in ES
Clinical: Acute cholangitis Sphincter of Oddi Dysfunction Coagulopathy Technical: Difficult cannulation Pre-cut Small ducts Wide ducts
Neoptolemos J P, et al Br Med J. 1987;294:470-4 Prospective randomised study of preoperative endoscopic sphincterotomy versus surgery alone for common bile duct stones No advantage for ES+cholecystectomy over BDE Routine preoperative ES is of questionable value
ES + surgery
Surgery alone ES alone GB in situ ES alone NO GB
59
248 114 17
5.1%
4% 7.9% 17.6%
5000 4500 4000 3500 3000 2500 2000 1500 1000 500 0 1989/90 1990/91 1991/92 1992/93 1993/94 1994/95 1995/96 1996/97 1997/98 1998/99
ERCPs (OPCS4 J38:J45) recorded in any position Laparoscopic cholecystectomy (OPCSJ08.8, J18+Y50.8) Cholecystectomy & exploration of common bile duct (J18.2) recorded in any position Calculus of bile duct with/without cholangitis or cholocystitis recorded in any position* with any or no procedure recorded
Medicine
Total
6169
11196
11252
21652 8162 8197 16359 400 % 190 %
All ERCPs
15213
38011
250 %
Number of deaths and mortality rate for patients undergoing ERCP procedures and diagnosed with benign gallstone dise p Time period: January 1992 to December 2001
Ye a r 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001p Num be r of de a ths 48 66 79 63 107 105 119 76 88 60 3.4 3.5 3.7 2.6 4.2 4.1 4.3 2.7 3.2 2.3
Morta li ra te (%
Cetta F, CBD stones in the era of LC: changing treatments and new pathological entities. J Laparoendosc Surg 1994; 4:41-4
Need to preserve the Sphincter of Oddi SS & ES9-11% stone recurrence within 6 years increasing with time. Recurrent brown stones due to stasis & infection High rate of long term complications of ES Resist ES without proper indication even at expense of risk of increased complications in the first phases of LCBDE
AND Endoscopists!
Cotton P B
Is your sphincterotomy really safe - and necessary? Gastrointest endosc; 1996 44:752-5 It could be that too many people have found themselves inadequately trained and are stretching the indications to maintain their experience and income Baillie J Biliary sphincterotomy: less benign than once thought? curr gastroentrol rep;1999 2:102-6 Endoscopists must re-evaluate their use of endoscopic sphincterotomy in light of long-term complications in the data
year olds having sphincterotomies 34 year old, mother of three, dying after an ERCP for mild derangement of LFTs
Anecdote
No.
169; 14%. Late complications after ES for CBD 139 5 yr FU stones with GB in situ are rare(2%/year)
Cholecystectomy does not seem to be warranted
371 7.7 yr FU
447 16%. 164 ES only 145, 60 yrs 12%. Can also be treated with ERCP. ES or younger is reasonable even in young patients
Costamagna 529 11%, 2.8% multiple. ES is safe at 2002 334 5 yr FU long-term follow-up !!
0 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001p
Conclusions
ES still has complications and mortality Even if the rates are the same, 2-3 times as many patients are exposed to the risk Main indication in laparoscopic era!? We should not forget the patient Evidence for one-session management is stronger Guidelines, Training and Specialisation